Small but focused Qualyst Transporter Solutions is a boutique biotechnology research provider with a specialized in vitro hepatic model platform, indicating a potential for targeted outsized impact with pharmaceutical, nutrition, cosmetics, and chemical clients seeking liver-related predictive data.

Acquisition history Historically acquired by BioIVT in 2017, Qualyst presents an opportunity for cross-sell within a larger laboratory services ecosystem or potential collaboration leverage through BioIVT’s extensive customer base and distribution channels.

Revenue range Current revenue is in the low seven figures, signaling room to scale with enterprise customers and long-term contracts across pharma, biotech, and consumer product industries that require hepatic model data for regulatory submissions.

Regulatory value Qualyst’s hepatic models emphasize superior in vitro–in vivo correlation and regulatory relevance, creating sales leverage with teams focused on drug safety, liver risk assessment, and regulatory submissions who need trustworthy liver data.

Tech and stack Existing tech footprint includes standard web and hosting stack (Varnish, jQuery, CentOS, Apache), suggesting straightforward modernization or integration with client-side portals and data-sharing platforms to enhance customer experience and data accessibility.